Why the study?
Does amino acid heterogeneity in the E2/NS1 viral protein correlate with responsiveness to interferon therapy in patients with chronic hepatitis C?
Population
6 patients with chronic hepatitis C virus infection treated with interferon-beta
Design
Case_series
Follow-up
6 months
Authors
Loading...
HCV E2/NS1 heterogeneity was associated with interferon nonresponse; hypothesis-generating and requires prospective validation before clinical use.
Does amino acid heterogeneity in the E2/NS1 viral protein correlate with responsiveness to interferon therapy in patients with chronic hepatitis C?
High variability in the E2/NS1 hypervariable region 1 of the hepatitis C virus is associated with nonresponsiveness to interferon therapy.
Okada et al. (1992) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: